BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6565289)

  • 41. High usual dietary vitamin K intake is associated with low relative variability in vitamin K intake: implications for anticoagulant therapy.
    Presse N; Kergoat MJ; Ferland G
    Br J Haematol; 2011 Apr; 153(1):129-30. PubMed ID: 21275964
    [No Abstract]   [Full Text] [Related]  

  • 42. Counteracting the effects of anticoagulants and antiplatelet agents during neurosurgical emergencies.
    Powner DJ; Hartwell EA; Hoots WK
    Neurosurgery; 2005 Nov; 57(5):823-31; discussion 823-31. PubMed ID: 16284551
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Treatment with anticoagulants; effect of various antibiotics on blood coagulation].
    SARTORI C
    Medizinische; 1955 Jul; (29-30):1026-30. PubMed ID: 13253217
    [No Abstract]   [Full Text] [Related]  

  • 44. New oral anticoagulants--what the cardiothoracic surgeon needs to know.
    Kaneko T; Yammine M; Aranki SF
    J Thorac Cardiovasc Surg; 2014 Nov; 148(5):1794-1801.e1. PubMed ID: 24973923
    [No Abstract]   [Full Text] [Related]  

  • 45. [Anticoagulant action of a new synthetic derivative of 4-hydroxycoumarin and antagonism by synthetic vitamin K1 in the rat].
    Thonnart N; Letist D; Reuse JJ
    C R Seances Soc Biol Fil; 1973; 167(6):1081-5. PubMed ID: 4803162
    [No Abstract]   [Full Text] [Related]  

  • 46. [Anticoagulants (heparin, antivitamins K, principles and rules of use)].
    Lecompte T; Horellou MH
    Rev Prat; 1992 May; 42(10):1280-8. PubMed ID: 1609224
    [No Abstract]   [Full Text] [Related]  

  • 47. Oral anticoagulant initiation: rationale for the use of warfarin dosing nomograms.
    Crowther MA
    Semin Vasc Med; 2003 Aug; 3(3):255-60. PubMed ID: 15199458
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interpretation of coagulation test results under direct oral anticoagulants.
    Mani H
    Int J Lab Hematol; 2014 Jun; 36(3):261-8. PubMed ID: 24750672
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of intravenous and intramuscular paritol on the clotting time.
    BEAZLEY HL; FOSTER WJ; ORY AA; CHAPMAN DW
    Am J Med Sci; 1953 Sep; 226(3):275-80. PubMed ID: 13080268
    [No Abstract]   [Full Text] [Related]  

  • 50. [Laboratory diagnostic with regard to new anticoagulants - monitoring and influence on coagulation tests].
    Nagler M; Wuillemin W
    Ther Umsch; 2012 Nov; 69(11):650-6. PubMed ID: 23117668
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Current pharmacological aspects of antithrombotic drugs].
    Stroescu V
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1976; 28(5):325-7. PubMed ID: 14367
    [No Abstract]   [Full Text] [Related]  

  • 52. [Interactions between chemotherapeutics and other drugs].
    Witkowska M; Prandota J
    Postepy Hig Med Dosw; 1976; 30(6):845-59. PubMed ID: 1023173
    [No Abstract]   [Full Text] [Related]  

  • 53. Effects of anti-inflammatory, anticoagulant and vasoactive compounds on tail bleeding time, whole blood coagulation time and platelet retention by glass beads in rats.
    De Clerck F; Goossens J; Reneman R
    Thromb Res; 1976 Feb; 8(2):179-93. PubMed ID: 1251349
    [No Abstract]   [Full Text] [Related]  

  • 54. Oral and parenteral anticoagulants: new kids on the block.
    Aditya S
    J Postgrad Med; 2012; 58(4):275-85. PubMed ID: 23298923
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Is Anticoagulation with Novel Oral Anticoagulants an Effective Treatment for Tuberculosis Patients not Achieving a Therapeutic Range with Vitamin K Antagonists? A Systematic Review.
    Fiore M; Maraolo AE; Chiodini P; Cerchione C; Gentile I; Borgia G; Pace MC
    Cardiovasc Hematol Disord Drug Targets; 2017; 17(2):105-110. PubMed ID: 28676032
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quick reference guide to the new oral anticoagulants.
    Hurst K; Lee R; Handa A
    J Vasc Surg; 2016 Jun; 63(6):1653-7. PubMed ID: 27113315
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The influence of epsilon-aminocaproic acid derivatives on the anticoagulant activity of heparin.
    Midura-Nowaczek K; Bruzgo I; Worowski K; Roszkowska-Jakimiec W
    Rocz Akad Med Bialymst; 1998; 43():228-31. PubMed ID: 9972059
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antibacterial prescribing and warfarin: a review.
    Rice PJ; Perry RJ; Afzal Z; Stockley IH
    Br Dent J; 2003 Apr; 194(8):411-5. PubMed ID: 12778089
    [No Abstract]   [Full Text] [Related]  

  • 59. [Influencing of blood coagulation and decoagulation of the blood].
    van der Kuy A; van den Benmd AA; Beysens AJ
    Tijdschr Ziekenverpl; 1975 Apr; 28(8):377-8. PubMed ID: 1039186
    [No Abstract]   [Full Text] [Related]  

  • 60. [Effect of subcutaneous administration of lactobionic acid on coagulation and platelet function].
    Kirchmaier CM; Lindhoff E; Basic-Micic M; Breddin HK
    Vasa Suppl; 1991; 33():168. PubMed ID: 1788660
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.